- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05255549
Feasibility of ESWT Treatment in Post-stroke Patients With Triceps Sural Spasticity (Waves2021)
ESWT Treatment in Post-stroke Patients With Triceps Sural: a Feasibility RCT
The main objective is to evaluate the feasibility of two different rehabilitation protocols that differed from the number of treatment sessions (1 session of ESWT versus 3 weekly sessions of ESWT), in patients with triceps surae spasticity after stroke. In both arms the other ESWT parameters (types of ESWT, intensity, frequency, location) and stretching sessions are the same.
Secondary objectives: to compare functional performances in these two groups of patients receiving the different rehabilitation protocol with ESWT, using the following parameters:
- Six Minutes walking test (6MWT) ; - Time Up & Go (TUG); - Modified Ashworth scale (MAS); - Lower Extremity Functional Scale (LEFS); - passive ankle range of motion (p-ROM), pain (NRS); and presence of ankle clonus. These parameters are assessed during baseline (T0), after 4 weeks (T1) and after 12 weeks (T2).
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Forventet)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Stefania Testoni, Dr
- Telefonnummer: +39 0522296163
- E-post: stefania.testoni@ausl.re.it
Studiesteder
-
-
Emilia Romagna
-
Reggio Emilia, Emilia Romagna, Italia, 42123
- Rekruttering
- Operational Unit of Physical Medicine and Rehabilitation AUSL - IRCCS Reggio Emilia
-
Ta kontakt med:
- Stefania Testoni, Dr
- Telefonnummer: +39 0522296163
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Adult patients of legal age
- Time elapsed since the stroke between 6 and 60 months
- Autonomous or supervised walking with or without aids
- Spasticity of the sural triceps> 1 on the MAS scale
Exclusion Criteria:
- Joint stiffness of the lower limbs due to other pathologies (ex orthopedic or rheumatological);
- Conditions that interfere with evaluation or collaboration in rehabilitation treatment (major psychiatric illnesses, clearly detectable cognitive deficits, severe pre-existing disabilities, sensory disturbances, etc.)
- Focal antispasmodic toxin treatments in the previous 3 months or phenolic blocks in the previous 9 months in the treatment region
- Treatments with central antispasmodic drugs with dosage modifications in the last week of starting treatment
- Individual neurorehabilitation treatments in progress
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Gruppe I
|
3 weeks intervention:
|
Sham-komparator: Group II
|
3 weeks intervention:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Feasibility of two kind treatments proposed
Tidsramme: T1 after 4 weeks from T0 (Enrollment)
|
The intervention is feasible if at least 80% of the enrolled patients complete the entire treatment foreseen in the allocation group
|
T1 after 4 weeks from T0 (Enrollment)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change in Walking Resistance
Tidsramme: T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
6 minute walking test
|
T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
Change in Level of mobility and balance
Tidsramme: T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
Timed Up & Go Test
|
T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
Change in spasticity
Tidsramme: T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
Modified Ashworth Scale (MAS).
Score from 0 to 4, higher scores mean a worse outcome
|
T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
Change in Passive ROM of the ankle in dorsiflexion
Tidsramme: T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
Passive ankle Range of Motion (p-ROM)
|
T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
Change in Leg Pain
Tidsramme: T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
Numeric Pain Rating Scale (NPRS) Score from 0 to 10, higher scores mean a worse outcome
|
T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
Change in Ability to carry out activities of daily living
Tidsramme: T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
Lower Extremity Functional Scale (LEFS).
Score from 0 to 80, higher scores mean a better outcome.
|
T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
Change in triceps clones
Tidsramme: T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
Presence of ankle clonus
|
T0 Enrollment, T1 after 4 weeks from T0, T2 after 12 weeks from T0
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Stefania Testoni, Dr, Azienda AUSLRE
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 31032021
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på ESWT + Stretching
-
University of BeykentRekruttering
-
Taipei Medical University WanFang HospitalUkjent
-
Ankara UniversityRekruttering
-
University of SharjahHar ikke rekruttert ennå
-
Afyonkarahisar Health Sciences UniversityFullførtMuskel- og skjelettsykdommer | Albue senebetennelse | Lateral epikondylitt | Blodplate-rik plasma (PRP)Tyrkia
-
Yuzuncu Yıl UniversityFullførtHalebeinslidelseTyrkia
-
Krishnadevaraya College of Dental Sciences & HospitalFullført
-
Fundación Garcia CugatFullførtMyofascial smertesyndromSpania
-
Mahidol UniversityFullført
-
AUVA Trauma Center MeidlingUkjentRyggmargsskaderØsterrike